Discovery of novel 2,4-diarylaminopyrimidine hydrazone derivatives as potent anti-thyroid cancer agents capable of inhibiting FAK

Hongting Li(First Affiliated Hospital of Zhengzhou University), Lijun Fu(First Affiliated Hospital of Zhengzhou University)
Journal of Enzyme Inhibition and Medicinal Chemistry
November 19, 2024
Cited by 4


Related Papers